Bibliografías temáticas / Dopamine type I receptor

Índice

  1. Artículos de revistas
  2. Tesis
  3. Libros
  4. Capítulos de libros
  5. Actas de conferencias
  6. Informes

Literatura académica sobre el tema "Dopamine type I receptor"

Autor: Grafiati
Publicado: 19 de octubre de 2024
Última modificación: 31 de julio de 2025

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Dopamine type I receptor".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Dopamine type I receptor"

1

Sarkar, D. K., K. Chaturvedi, S. Oomizu, N. I. Boyadjieva та C. P. Chen. "Dopamine, Dopamine D2 Receptor Short Isoform, Transforming Growth Factor (TGF)-β1, and TGF-β Type II Receptor Interact to Inhibit the Growth of Pituitary Lactotropes". Endocrinology 146, № 10 (2005): 4179–88. http://dx.doi.org/10.1210/en.2005-0430.

Texto completo
Resumen
The neurotransmitter dopamine is known to inhibit prolactin secretion and the proliferation of lactotropes in the pituitary gland. In this study, we determined whether dopamine and TGFβ1 interact to regulate lactotropic cell proliferation. We found that dopamine and the dopamine agonist bromocriptine stimulated TGFβ1 secretion and TGFβ1 mRNA expression but inhibited lactotropic cell proliferation both in vivo and in vitro. The dopamine’s inhibitory action on lactotropic cell proliferation was blocked by a TGFβ1-neutralizing antibody. We also found that PR1 cells, which express low amounts of t
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Peiser, Christian, Marcello Trevisani, David A. Groneberg, et al. "Dopamine type 2 receptor expression and function in rodent sensory neurons projecting to the airways." American Journal of Physiology-Lung Cellular and Molecular Physiology 289, no. 1 (2005): L153—L158. http://dx.doi.org/10.1152/ajplung.00222.2004.

Texto completo
Resumen
Agonists of the dopamine receptors have been demonstrated to have bronchodilatory properties in pathologically constricted airways. The mechanism by which these agonists induce bronchodilatation is thought to involve airway sensory nerves. In this study, the expression and function of dopamine D2 receptor were examined in sensory ganglia supplying the airways. Neuronal dopamine D2 receptor mRNA expression was demonstrated by single-cell RT-PCR following laser-assisted microdissection. The projection of the neurons to the airways was confirmed by retrograde neuronal labeling. In functional stud
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Myslivecek, Jaromir. "Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors." Life 12, no. 5 (2022): 606. http://dx.doi.org/10.3390/life12050606.

Texto completo
Resumen
The dopaminergic system is one of the most important neurotransmitter systems in the central nervous system (CNS). It acts mainly by activation of the D1-like receptor family at the target cell. Additionally, fine-tuning of the signal is achieved via pre-synaptic modulation by the D2-like receptor family. Some dopamine drugs (both agonists and antagonists) bind in addition to DRs also to α2-ARs and 5-HT receptors. Unfortunately, these compounds are often considered subtype(s) specific. Thus, it is important to consider the presence of these receptor subtypes in specific CNS areas as the functi
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Shariati, G. H., G. Ahangari, M. R. Asadi, F. Poyafard, and H. R. Ahmadkhaniha. "Dopamine Receptor Gene Expression Changes in Peripheral Blood Mononuclear Cells from Schizophrenic Patients Treated with Haloperidol and Olanzapine." European Journal of Inflammation 7, no. 2 (2009): 71–76. http://dx.doi.org/10.1177/1721727x0900700203.

Texto completo
Resumen
We investigated dopamine receptor gene expression in peripheral blood mononuclear cells of schizophrenic patients before and after treatment. Also dopamine receptor genes expression profile was compared in two treatment groups including haloperidol and olanzapine. The peripheral blood mononuclear cells were separated from whole blood by Ficoll-hypaque; the total cellular RNA was extracted and the cDNA was synthesized. This process was followed by real-time polymerase chain reaction using primer pairs specific for five dopamine receptor mRNAs and β-actin as internal control. The results show th
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Helms, My N., Xi-Juan Chen, Semra Ramosevac, Douglas C. Eaton, and Lucky Jain. "Dopamine regulation of amiloride-sensitive sodium channels in lung cells." American Journal of Physiology-Lung Cellular and Molecular Physiology 290, no. 4 (2006): L710—L722. http://dx.doi.org/10.1152/ajplung.00486.2004.

Texto completo
Resumen
Dopamine increases lung fluid clearance. This is partly due to activation of basolateral Na-K-ATPase. However, activation of Na-K-ATPase by itself is unlikely to produce large changes in transepithelial transport. Therefore, we examined apical and basolateral dopamine's effect on apical, highly selective sodium channels [epithelial sodium channels (ENaC)] in monolayers of an alveolar type 2 cell line (L2). Dopamine increased channel open probability ( Po) without changing the unitary current. The D1 receptor blocker SCH-23390 blocked the dopamine effect, but the D2 receptor blocker sulpiride d
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Ding, Guoliang, Rob F. Wiegerinck, Ming Shen, Anca Cojoc, Carlo M. Zeidenweber та Mary B. Wagner. "Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and β2 receptors". American Journal of Physiology-Heart and Circulatory Physiology 294, № 5 (2008): H2327—H2335. http://dx.doi.org/10.1152/ajpheart.00993.2007.

Texto completo
Resumen
Dopamine is used to treat heart failure, particularly after cardiac surgery in infants, but the mechanisms of action are unclear. We investigated differences in the effect of dopamine on L-type calcium current ( ICa) between newborn (NB, 1–4 days) and adult (AD, 3–4 mo) rabbit ventricular myocytes. Myocytes were enzymatically dissociated from NB and AD rabbit hearts. ICa was recorded by using the whole cell patch-clamp technique. mRNA levels of cardiac dopamine receptor type 1 (D1), type 2 (D2), and β-adrenergic receptors (β-ARs) were measured by real-time RT-PCR. Dopamine (100 μM) increased I
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

MORA-FERRER, CARLOS, and VOLKER GANGLUFF. "D2-dopamine receptor blockade impairs motion detection in goldfish." Visual Neuroscience 17, no. 2 (2000): 177–86. http://dx.doi.org/10.1017/s0952523800171196.

Texto completo
Resumen
Under photopic illumination conditions, motion detection in goldfish is dominated by the long-wavelength-sensitive cone type (L-cone), and under scotopic conditions motion it is determined by rods (Schaerer & Neumeyer, 1996). The switch from rod-dominated to cone-dominated motion detection occurs during light adaptation. It has been suggested that dopamine acts as a neuronal light-adaptative signal. It is known that dopamine affects wavelength discrimination through D1-dopamine receptors (Mora-Ferrer & Neumeyer, 1996), and the dorsal light reflex through D1- and D2-dopamine receptors (
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Hayashida, Yuki, and Andrew T. Ishida. "Dopamine Receptor Activation Can Reduce Voltage-Gated Na+ Current by Modulating Both Entry Into and Recovery From Inactivation." Journal of Neurophysiology 92, no. 5 (2004): 3134–41. http://dx.doi.org/10.1152/jn.00526.2004.

Texto completo
Resumen
We tested whether dopamine receptor activation modulates the voltage-gated Na+ current of goldfish retinal ganglion cells, using a fast voltage-clamp amplifier, perforated-patch whole cell mode, and a physiological extracellular Na+ concentration. As found in other cells, activators of D1-type dopamine receptors and of protein kinase A reduced the amplitude of current activated by depolarizations from resting potential without altering the current kinetics or activation range. However, D1-type dopamine receptor activation also accelerated the rate of entry into inactivation during subthreshold
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Milienne-Petiot, Morgane, Lucianne Groenink, Arpi Minassian, and Jared W. Young. "Blockade of dopamine D1-family receptors attenuates the mania-like hyperactive, risk-preferring, and high motivation behavioral profile of mice with low dopamine transporter levels." Journal of Psychopharmacology 31, no. 10 (2017): 1334–46. http://dx.doi.org/10.1177/0269881117731162.

Texto completo
Resumen
Background: Patients with bipolar disorder mania exhibit poor cognition, impulsivity, risk-taking, and goal-directed activity that negatively impact their quality of life. To date, existing treatments for bipolar disorder do not adequately remediate cognitive dysfunction. Reducing dopamine transporter expression recreates many bipolar disorder mania-relevant behaviors (i.e. hyperactivity and risk-taking). The current study investigated whether dopamine D1-family receptor blockade would attenuate the risk-taking, hypermotivation, and hyperactivity of dopamine transporter knockdown mice. Methods
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Pedarzani, P., and J. F. Storm. "Dopamine modulates the slow Ca(2+)-activated K+ current IAHP via cyclic AMP-dependent protein kinase in hippocampal neurons." Journal of Neurophysiology 74, no. 6 (1995): 2749–53. http://dx.doi.org/10.1152/jn.1995.74.6.2749.

Texto completo
Resumen
1. The effects of dopamine on the slow Ca(2+)-dependent K+ current (IAHP; AHP, afterhyperpolarization) and spike frequency adaptation were studied by whole cell voltage-clamp and sharp microelectrode current-clamp recordings in rat CA1 pyramidal neurons in rat hippocampal slices. 2. Dopamine suppressed IAHP in a dose-dependent manner, under whole cell voltage-clamp conditions. Similarly, under current-clamp conditions, dopamine inhibited spike frequency adaptation and suppressed the slow afterhyperpolarization. 3. The effect of dopamine on IAHP was mimicked by a D1 receptor agonist and blocked
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Dopamine type I receptor"

1

Hatcher-Solis, Candice N. "PHARMACOLOGICAL IMPLICATIONS OF ADENOSINE 2A RECEPTOR- DOPAMINE TYPE 2 RECEPTOR HETEROMERIZATION." VCU Scholars Compass, 2016. http://scholarscompass.vcu.edu/etd/4458.

Texto completo
Resumen
G protein-coupled receptors (GPCRs) are heptahelical, transmembrane proteins that mediate a plethora of physiological functions by binding ligands and releasing G proteins that interact with downstream effectors. GPCRs signal as monomers, complexes of the same receptor subtype (homomers), or complexes of different receptor subtypes (heteromers). Recently, heteromeric GPCR complexes have become attractive targets for drug development since they exhibit distinct signaling and cell-specific localization from their homomeric counterparts. Yet, the effect of heteromerization on the pharmacology of
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

ZANINOVICH, OREL ANTHONY. "THE CLONING OF AN INDR-TYPE DOPAMINE RECEPTOR IN MANDUCA SEXTA." Thesis, The University of Arizona, 2008. http://hdl.handle.net/10150/192256.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Mann, Miranda Jane. "A neuropsychological investigation of dopamine receptor 4 differences among attention deficit hyperactivity disorder-combined type and control children /." Digital version accessible at:, 2000. http://wwwlib.umi.com/cr/utexas/main.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Gorji, Hassan. "Role of adenylyl cyclase type 5 in the regulation of the dopamine D3 receptor phosphorylation." Thesis, University of Ottawa (Canada), 2006. http://hdl.handle.net/10393/27364.

Texto completo
Resumen
Adenylyl cyclase type 5 (AC5) is expressed in the brain where the highest density of the dopamine D3 receptor (D3R) has been found. The D3R-mediated Gi/o protein activation leads to a specific inhibition of AC5. Therefore, as AC5 is the main signalosome partner of D3R, I hypothesize that D3R phosphorylation is differentially regulated in cells expressing AC5. In HEK293 cells expressing D3R alone, D3R undergo dopamine-induced phosphorylation. Interestingly, in cells co-expressing AC5 and D3R, D3R undergoes a Galphai-dependent dephosphorylation upon dopamine exposure while retaining its ability
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Maier, Annette Louise. "Comparative regional ontogeny of dopamine D₁ receptor binding and mRNA expression in pre- and postnatal rat brain /." Zürich, 1994. http://e-collection.ethbib.ethz.ch/show?type=diss&nr=10902.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Etchepare, Laetitia. "Role of glutamate N-Methyl-D-Aspartate receptor surface trafficking in the firing pattern of midbrain dopaminergic neurons." Thesis, Bordeaux, 2017. http://www.theses.fr/2017BORD0849/document.

Texto completo
Resumen
Les neurones dopaminergiques (DA) mésencéphaliques jouent un rôle prépondérant dans de nombreuses fonctions cérébrales telles que la motivation, mais ils sont également impliques dans l’émergence de pathologies telles que la maladie de Parkinson et l’addiction aux drogues. Ces processus ayant en commun de modifier l’activité de décharge des neurones DA mésencéphaliques, il est d’une importance primordiale de comprendre les mécanismes sous-tendant cette activité. Parmi les différents canaux ioniques et récepteurs impliques dans la génération de l’activité de décharge des neurones DA, les récept
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Roberts-Crowley, Mandy L. "Modulation of Cav1.3 L-Type Calcium Channels by Arachidonic Acid and Muscarinic M1 Receptors: A Dissertation." eScholarship@UMMS, 2007. https://escholarship.umassmed.edu/gsbs_diss/348.

Texto completo
Resumen
Membrane excitability, gene expression, and neurotransmitter release are all controlled by voltage-gated L-type Ca2+ (L- )channels. In turn, Ca2+ channels are highly regulated by signal transduction cascades initiated by G protein-coupled receptor (GPCR) activation. In medium spiny neurons of the striatum, both the muscarinic M1 receptors (M1R) and dopaminergic D2 receptors (D2R) specifically inhibit the Cav1.3 L-channel. In Chapters III and IV, the pathways downstream of M1Rs and D2Rs are examined to determine whether an overlap or intersection in inhibition of Cav1.3 occurs by these two rece
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Lucas, Guillaume. "Etude in vivo des modalités d'intervention de la sérotonine et des récepteurs sérotoninergiques de type 5-HT/2A/2C, 5-HT3 et 5-HT4 dans le contrôle de la transmission dopaminergique nigro-striée et mésoaccumbale chez le rat." Bordeaux 2, 1999. http://www.theses.fr/1999BOR28692.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Hegron, Alan. "Implication des récepteurs de la mélatonine dans les troubles neurologiques et le diabète de type 2 et identification de régions clés du récepteur MT1 responsables de sa sélectivité fonctionnelle." Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLS555/document.

Texto completo
Resumen
La mélatonine est une neurohormone produite principalement par la glande pinéale de manière circadienne et agissant par l’activation de deux récepteurs couplés aux protéines G (RCPGs) appelés MT1 et MT2. La mélatonine régule de nombreuses fonctions physiologiques importantes. La régulation des niveaux de dopamine (DA) et de glucose en font partie mais nous ne savons pas clairement comment la mélatonine les régule.Les niveaux de DA extracellulaire sont principalement régulés par son transporteur (DAT) responsable de sa recapture dans les neurones présynaptiques afin de prévenir d’une hyperactiv
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Thirtamara, Rajamani Keerthi Krishnan. "Animal Models of Drug Addiction and Autism Spectrum Disorders." The Ohio State University, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=osu1386011455.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Dopamine type I receptor"

1

Tupala, Erkki. Dopamine receptors and transporters in type 1 and 2 alcoholism measured with postmortem human whole hemisphere autoradiography. University of Kuopio, 2001.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Tiberi, Mario. Dopamine receptor technologies. Humana Press, 2015.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Tiberi, Mario, ed. Dopamine Receptor Technologies. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2196-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Donthamsetti, Prashant Chandra. Dissecting Dopamine D2 Receptor Signaling. [publisher not identified], 2015.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

L, Waddington John, ed. D1:D2 dopamine receptor interactions. Academic Press, 1993.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Boileau, Isabelle, and Ginetta Collo, eds. Therapeutic Applications of Dopamine D3 Receptor Function. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23058-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Knapp, Mark. Development of dopamine receptor expressing adenoviral vectors. National Library of Canada, 1997.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

R, Demirdamar, and Jenner Peter 1946-, eds. Dopamine receptor subtypes: From basic science to clinical application. IOS Press, 1998.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Ray, Avi Andrew. SH3 binding domains in the dopamine D(3) receptor. National Library of Canada, 1999.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Zawarynski, Paul. Dopamine D2 receptor monomers, dimers and higher order oligomers. National Library of Canada, 1998.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Dopamine type I receptor"

1

Turco, Raymond. "Dopamine Receptor." In Encyclopedia of Animal Cognition and Behavior. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47829-6_1256-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Turco, Raymond. "Dopamine Receptor." In Encyclopedia of Animal Cognition and Behavior. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-319-55065-7_1256.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Fuxe, Kjell, Daniel Marcellino, Diego Guidolin, Amina Woods, and Luigi Agnati. "Dopamine Receptor Oligomerization." In The Dopamine Receptors. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-333-6_10.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Chaudhary, Tanvi, Debashruti Das, Olivia Majhi, and Amrita Mukhopadhyay. "Dopamine Receptor D4." In Encyclopedia of Sexual Psychology and Behavior. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-08956-5_808-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Hazelwood, Lisa A., R. Benjamin Free, and David R. Sibley. "Dopamine Receptor-Interacting Proteins." In The Dopamine Receptors. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-333-6_9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Deth, Richard C. "The Dopamine D4 Receptor." In Molecular Origins of Human Attention. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0335-4_4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Richtand, Neil M., Laurel M. Pritchard, and Lique M. Coolen. "Dopamine Receptor Alternative Splicing." In Dopamine and Glutamate in Psychiatric Disorders. Humana Press, 2005. http://dx.doi.org/10.1007/978-1-59259-852-6_2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Civelli, Olivier, James Bunzow, Paul Albert, Hubert H. M. Van Tol, and David Grandy. "The Dopamine D2 Receptor." In Molecular Biology of G-Protein-Coupled Receptors. Birkhäuser Boston, 1992. http://dx.doi.org/10.1007/978-1-4684-6772-7_7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Cepeda, Carlos, Véronique M. André, Emily L. Jocoy, and Michael S. Levine. "Dopamine Receptor Modulation of Glutamatergic Neurotransmission." In The Dopamine Receptors. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-333-6_11.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Lee, Frankie H. F., and Albert H. C. Wong. "Dopamine Receptor Genetics in Neuropsychiatric Disorders." In The Dopamine Receptors. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-333-6_19.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Dopamine type I receptor"

1

Kamasak, Mustafa E., Charles A. Bouman, Bradley T. Christian, and Evan D. Morris. "Imaging D2-Dopamine Receptor using PET." In 2007 IEEE 15th Signal Processing and Communications Applications. IEEE, 2007. http://dx.doi.org/10.1109/siu.2007.4298698.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Moritz, Amy E., Nora S. Madaras, Kirsten K. Snyder, et al. "Regulation of Dopamine Receptor Subtypes by G Protein-Coupled Receptor Kinase Isoforms." In ASPET 2024 Annual Meeting Abstract. American Society for Pharmacology and Experimental Therapeutics, 2024. http://dx.doi.org/10.1124/jpet.159.988010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Liu, X., J. Guan, F. Tao, and B. Mao. "Acupuncture Zusanli Regulate COPD Inflammation Through Dopamine D2 Receptor." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4755.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Harrison, J. M., I. Nir, M. Rubinstein, M. J. Low, D. K. Grandy, and P. M. Iuvone. "Retinal Function in Dopamine D4 Receptor Knockout (D4KO) Mice." In Vision Science and its Applications. OSA, 2000. http://dx.doi.org/10.1364/vsia.2000.fd2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Javadi, Arman, Nicholas Forsythe, Alaa Refaat, et al. "Abstract 3448: Targeting the dopamine receptor 2 inBRAFmutant colorectal cancer." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-3448.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Uysal, Mehmet Atilla, Ulgen Sever, and Sacide Pehlivan. "The dopamine receptor D4 VNTR 48bp gene variant in nicotine addiction." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.oa1486.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Raghuraman, Gayatri, Nanduri R. Prabhakar, and Ganesh K. Kumar. "Dopamine D1 Receptor Signaling Mediates Altered GABA Synthesis By Intermittent Hypoxia." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6630.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Blake, Keyana, Basant Hens, and Anthony J. Baucum. "Investigating the role of spinophilin in mediating Dopamine D2 Receptor Activity." In ASPET 2024 Annual Meeting Abstract. American Society for Pharmacology and Experimental Therapeutics, 2024. http://dx.doi.org/10.1124/jpet.321.940880.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Wen, Ruojian, Xiaoqing Chen, Dan Huang, Minjie Chen, and Yuwei Liu. "Sleep Deprivation Increased Dopamine D2 Receptor Expression through Downregulation of miR-9." In 2015 7th International Conference on Information Technology in Medicine and Education (ITME). IEEE, 2015. http://dx.doi.org/10.1109/itme.2015.122.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Madaras, Nora S., Michele L. Rankin, R. Benjamin Free, et al. "Delineation of the G Protein-Coupled Receptor Kinase Phosphorylation Sites Within the D1 Dopamine Receptor and Their Role in Regulating Receptor Function." In ASPET 2023 Annual Meeting Abstracts. American Society for Pharmacology and Experimental Therapeutics, 2023. http://dx.doi.org/10.1124/jpet.122.154110.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Informes sobre el tema "Dopamine type I receptor"

1

Dr. Jogeshwar Mukherjee. Development of dopamine receptor radiopharmaceuticals for the study of neurological and psychiatric disorders. Office of Scientific and Technical Information (OSTI), 2009. http://dx.doi.org/10.2172/944919.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Mukherjee, J. Development of dopamine receptor radiopharmaceuticals for the study of neurological and psychiatric disorders. Progress report 1994--1997. Office of Scientific and Technical Information (OSTI), 1999. http://dx.doi.org/10.2172/764610.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Reiss, Michael. Type I Receptor Kinase Inhibitors - A Novel Treatment for Breast Cancer. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada408030.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Fagan, Dedra. Type-I Insulin-Like Growth Factor Receptor (IGF1R)-Estrogen Receptor (ER) Crosstalk Contributes to Antiestrogen Therapy Resistance in Breast Cancer Cells. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada575846.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Reise, Michael. TGF-beta Type I Receptor Kinase Inhibitors - A Novel Treatment for Breast Cancer. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada416442.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Rausch, Matthew. Enhancement of Dendritic Cell-Based Immunotherapy Using a Small Molecule TGF-beta Receptor Type I Kinase Inhibitor. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada487435.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Plymate, Stephen R. Therapy of Prostate Cancer Using a Human Antibody Targeting the Type 1 Insulin-Like Growth Factor Receptor (IGF-IR). Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada524529.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Thomas, Tania, S. Shappell, S. Kasper, R. A. Serra, and H. L. Moses. The Development and Characterization of a Transgenic Mouse Model Over-Expressing a Truncated TGF(Beta) Type II Receptor in the Prostate. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada390670.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Deo, Salil, David McAllister, Naveed Sattar, and Jill Pell. The time-varying cardiovascular benefits of glucagon like peptide-1 agonist (GLP-RA)therapy in patients with type 2 diabetes mellitus: A meta-analysis of multinational randomized trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.7.0097.

Texto completo
Resumen
Review question / Objective: P - patients with type 2 diabetes melllitus already receiving routine medical therapy; I - patients receiving glucagon like peptide 1 receptor agonist (GLP1 receptor agonist) therapy (semaglutide, dulaglutide, liraglutide, exenatide, lixisenatide, efpeglenatide, abiglutide); C - patients receiving standard therapy for diabetes mellitus but not receiving GLP1 agonist therapy; O - composite end point as per invididual trial, cardiovascular mortality, all-cause mortality, myocardial infarction, stoke. Condition being studied: Type 2 diabetes mellitus. Study designs to
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Zhuo, Chuanjun, Hongjun Tian, Lina Wang, Xiangyang Gao, Li Ding, and Ming Liu. Comparative safety of glucagon like peptide‑1 receptor agonists in patients with type 2 diabetes: a network meta-analysis of cardiovascular outcome trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.8.0122.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Dopamine type I receptor" para tipos de fuentes particulares:
Artículos de revistas Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía